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The GA-binding protein (GABP) transcription factor has been shown in vitro to regulate the expression
of the neuromuscular proteins utrophin, acetylcholine esterase, and acetylcholine receptor subunits  and
 through the N-box promoter motif (5-CCGGAA-3), but its in vivo function remains unknown. A single
point mutation within the N-box of the gene encoding the acetylcholine receptor  subunit has been
identified in several patients suffering from postsynaptic congenital myasthenic syndrome, implicating the
GA-binding protein in neuromuscular function and disease. Since conventional gene targeting results in
an embryonic-lethal phenotype, we used conditional targeting to investigate the role of GABP in
neuromuscular junction and skeletal muscle development. The diaphragm and soleus muscles from
mutant mice display alterations in morphology and distribution of acetylcholine receptor clusters at the
neuromuscular junction and neurotransmission properties consistent with reduced receptor function.
Furthermore, we confirmed decreased expression of the acetylcholine receptor  subunit and increased
expression of the  subunit in skeletal muscle tissues. Therefore, the GABP transcription factor aids in
the structural formation and function of neuromuscular junctions by regulating the expression of postsyn-
aptic genes.
Congenital myasthenic syndrome (CMS), is a heterogeneous
disorder of neuromuscular transmission that occurs at a fre-
quency of 1/500,000 people (42). CMS can be classified as
presynaptic (i.e., choline acetyltransferase gene mutations),
synaptic (i.e., acetylcholine esterase gene [AChE] mutations),
or postsynaptic (i.e., acetylcholine receptor gene [AChR], or
Rapsyn, mutations) in origin (14). All cases of CMS identified
so far result in muscle weakness due to a lack of propagation
of the endplate potential (13, 14). Understanding the molecu-
lar basis of CMS, and other neuromuscular diseases, may lead
to the identification of potential therapies.
CMS is usually caused by missense mutations in the coding
regions of neuromuscular junction (NMJ) proteins, such as
ACh, AChE, or AChR subunits (30), or in postsynaptic AChR-
associated proteins, such as Rapsyn (33). These mutations
often result in structural changes of the AChR and altered
affinity for ACh (34). In addition, a homozygous mutation in
the N-box element (5-CCGGAA-3) of the AChRε promoter
results in a decreased number of AChRs and clinical symptoms
of CMS (30, 32). This C3T transition in the mouse AChRε
promoter results in a 90% decrease in binding of the ETS
transcription factor GA-binding protein (Gabp) (10).
The widely expressed ETS transcription factor Gabp regu-
lates genes essential for the function of the NMJ, such as
AChR and -ε (10, 23), AChE (3), and Utrophin (21), yet the
molecular mechanism by which Gabp regulates NMJ-specific
gene expression remains to be elucidated (39). In situ hybrid-
ization reveals that Gabp mRNA is slightly enriched at NMJs
relative to other muscle tissue, suggestive of synaptic function
(40). The Gabp complex is composed of an  subunit (con-
taining an ETS domain that binds a 5-GGAA-3 motif) and a
 subunit (providing a nuclear localization signal and a trans-
activation domain) (25). GABP is phosphorylated at specific
residues in both subunits in response to neuregulin-ErbB sig-
naling, with receptor binding resulting in activation of the ERK
and JNK serine-threonine kinases and, subsequently, the
GABP complex, which then binds the N-box promoter ele-
ments of target genes (17).
Skeletal-muscle-specific, ETS dominant-negative mice ex-
hibit muscles with small AChR patches and disorganized
postsynaptic junctional folds (7). However, the ETS factor
responsible for this phenotype was not identified. Our studies
suggest that Gabp is a likely candidate. Mice deficient in
Gabp die prior to implantation (35), thus restricting the use
of these mice to prove a function for Gabp in AChR regulation
in vivo. In this study, we examine the role of Gabp in skeletal
muscle development and function by conditional targeting of
Gabp. These mice demonstrate defects in AChR assembly
and synaptic transmission at the NMJ in skeletal muscle, high-
lighting the importance of Gabp in the development and func-
tion of postsynaptic structures at the NMJ.
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MATERIALS AND METHODS
Generation of a Gabp targeting construct. A 3.2-kb BamHI-EcoRI genomic
fragment, spanning introns 1 and 2 of Gabp (bp 6662 to 9873 of GenBank
accession no. GI:27960443), was inserted into the pBS KS vector (Stratagene,
La Jolla, CA) and constituted the 5 and 3 homologous sequences of the
targeting construct. Exon 2 of Gabp was removed by BclI digestion (bp 8212 to
8572 of GI:27960443) (35) and replaced with a 1.4-kb ApaI-NsiI fragment en-
compassing the floxed pMCI-Neomycin cassette. Finally, a 380-bp PCR product
containing Gabp exon 2 fused to a loxP site at its 5 end (spanning bp 8220 to
8562 of GI:27960443) was inserted at a unique AatII site at the 5 end of the
Neomycin cassette. A negative selection marker, thymidine kinase, under the
control of the Herpes simplex virus promoter, was introduced into the pBS KS()
vector backbone at a unique XhoI site.
Generation of Gabp floxed mice. Embryonic stem (ES) cells from mice of the
SvJ129 background strain were electroporated with the Gabp targeting con-
struct (linearized at a SacII site within the vector backbone) and selected for 7
days using Geneticin at 15 mg/ml and ganciclovir at 2 M, as previously de-
scribed (24). Selected colonies were screened by Southern blotting and subse-
quently electroporated with PGK-Cre recombinase and PGK-puromycin con-
structs. Conditionally targeted (floxed) ES cell clones were screened by PCR
following selection with 3 g/ml puromycin for 2 days prior to injection into
blastocysts from superovulated C57BL/6 female mice.
ES cell screening and generation of Gabp floxed ES cells. Ten micrograms of
genomic DNA was digested with 10 U BamHI overnight at 37°C prior to elec-
trophoresis and Southern blot capillary transfer onto Gene Screen Plus nylon
membrane (NEN, Boston, MA) according to the manufacturer’s instructions.
The membranes were hybridized as previously described (19), using a 977-bp
SacII-SpeI probe within Gabp intron 3 (bp 12695 to 13672 of GI:27960443) to
identify a 7-kb wild-type and a 5-kb targeted fragment, respectively. ES cell
clones were screened by PCR spanning intron 1 and intron 2 (primers G1f, 5-
GCTGTGCTTTGCCAGTGTTG-3, and G1r, 5-GACTAAGTGAGGACTAT
TGG-3), generating 1.5-kb, 1.8-kb, and 1.9-kb fragments from the knockout,
wild-type, and floxed alleles, respectively. The presence of the single loxP site
immediately upstream of exon 2 was confirmed by multiplex PCR, using a
common 5 primer within intron 1 (G2f, 5-CTCCTGAGGTCCCTGCTTTG-3)
and 3 primers within exon 2 (G2r, 5-GTCCCGTCGATCTCAATTTC-3) and
intron 2 (G1r, 5-GACTAAGTGAGGACTATTGG-3). This reaction gener-
ated 620-bp, 660-bp, and 740-bp fragments representing wild-type, floxed, and
knockout Gabp alleles, respectively.
Generation of Gabp skeletal-muscle-specific knockout mice. Gabp floxed
mice were intercrossed with mice expressing the Cre recombinase transgene
driven by the promoter of the human -skeletal actin gene (described in refer-
ence 28) to generate heterozygous conditional-knockout mice of genotype
GabpF/ HSAcre/. These mice (referred to here as /) were intercrossed to
confirm a Mendelian ratio of allelic inheritance. Animals used for phenotypic
analysis were generated from breeding homozygous floxed animals (GabpF/F,
referred to as wild type, or /, unless otherwise defined) with homozygous
conditional mutant mice (GabpF/F HSAcre/, referred to as /). Genomic
DNA was screened by PCR using 0.25 U Taq DNA Polymerase (Promega,
Madison, WI), with annealing at 50°C and a 1-min extension time. Gabp alleles
were amplified with primers G2f, G2r, and G1r in reaction mixtures containing
2 mM MgCl2. The Cre allele was detected by amplification with primers Cre-5
(5-CCGGTCGATGCAACGAGTGAT-3) and Cre-3 (5-ACCAGAGTCATC
CTTAGCGCC-3) in reaction mixtures containing 1.5 mM MgCl2. All experi-
ments using mice were carried out in accordance with Australian federal
regulations and approved by the Monash University ethics committee.
SDS-PAGE and Western blot immunodetection. Protein samples were pre-
pared, electrophoresed through 8% nonreducing polyacrylamide gels, and trans-
ferred onto Immobilon-P membranes (Millipore, Bedford, MA) as previously
described (37). Gabp protein was detected by overnight incubation at 4°C with
a rabbit polyclonal antibody generated against amino acids 40 to 147 (35) and
subsequent incubation with 0.15 g/ml goat anti-rabbit horseradish peroxidase-
conjugated immunoglobulin G (IgG) (DAKO, Carpinteria, CA) for 1 h at room
temperature prior to detection with SuperSignal West Pico Chemiluminescent
Substrate (Pierce, Rockford, IL) and exposure to film (BioMax MR; Kodak,
Rochester, NY). The film was developed in a Kodak X-OMAT 480 RA proces-
sor and scanned at 100 dots per inch using a Canon N1220U, and the intensities
of bands were determined using FujiFilm MacBAS v2.5 software. Protein levels
were quantified as a ratio to -tubulin by detection with 0.05 g/ml anti--tubulin
mouse monoclonal antibody (Boehringer-Mannheim, Mannheim, Germany),
followed by 0.3 g/ml rabbit anti-mouse horseradish peroxidase-IgG (DAKO,
Carpinteria, CA), and results from three animals per genotype were averaged
across three duplicate blots.
Real-time RT-PCR analysis. The rapid acid guanidinium thiocyanate-phenol-
chloroform method (5) was used for total-RNA preparation from mouse skeletal
muscle tissues. Samples were treated with DNase I (Promega, Madison, WI), and
	10 g of RNA was used as a template for first-strand cDNA synthesis using
avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI) and
oligo(dT) primer according to the manufacturer’s instructions. The relative ex-
pression levels of transcripts were determined using a Light Cycler (Roche,
Mannheim, Germany) real-time reverse transcription (RT)-PCR machine (v3.5
software) according to the manufacturer’s instructions and expressed as a ratio
relative to -actin. Specific primer sequences amplified the following RT-PCR
products: AChR, bp 1021 to 1830 of GI:191609; AChRε, bp 3 to 258 of
GI:2660742; utrophin, bp 10381 to 10603 of GI:1934962; Rapsyn, 827 to 918 bp
of GI:53804; and -actin, bp 344 to 446 of GI:49867.
Histology and fiber typing of skeletal muscle. Slides of transverse cryosections
(16 m) of skeletal muscle from 1-month-old mice were submerged in freshly
made NADH staining solution (1 mg/ml 4-nitro blue tetrazolium [Sigma, Saint
Louis, MO] and 0.8 mg/ml NADH [Sigma, Saint Louis, MO] dissolved in 0.2 M
Tris-HCl, pH 7.4) and incubated at 37°C for 25 min in the dark. The slides were
then rinsed in distilled water for 5 min prior to dehydration and mounting in
histolene (Amber Scientific, Selmont, WA, Australia) and DePex (BDH, Poole,
United Kingdom) solution. Images were taken with a Leica MPS60 digital
camera on a Leica DMR microscope (Leica Instruments, Nussloch, Germany)
at 
200 magnification.
Immunohistochemistry. Intact muscles were dissected and stained as previ-
ously described (22). For staining skeletal muscle tissue sections, dissected or-
gans were rinsed in phosphate-buffered saline (PBS) and embedded directly into
Tissue Tek optimal-cutting-temperature compound (OCT) (Sakura, Torrance,
CA). OCT blocks were slowly frozen by placement into a plastic tray filled with
100% (vol/vol) isopentane resting on a bed of dry ice. The OCT tissue blocks
were stored at80°C. Prior to use, the tissue blocks were thawed to20°C in the
cryostat chamber for 30 min. Tissue was sectioned at 16 m at 18°C using a
Leica CM 3050 cryostat, and the tissue was collected onto Superfrost Plus
(Menzel-Glaser, Braunschweig, Germany) glass slides. Prior to tissue staining,
the mounted slides were thawed to room temperature and washed in PBS for 5
min to rid them of excess OCT compound.
AChR clusters were detected using Texas red-conjugated -bungarotoxin
(Molecular Probes, Eugene, OR) at 1 g/ml. Nerves and synaptic terminals were
localized in whole-mount samples by immunohistochemistry with rabbit sera
raised against mouse 200-kDa neurofilament (8 g/ml; Sigma, Saint Louis, MO)
and human synaptophysin (1/50 neat sera; DAKO, Carpinteria, CA), and
AChR and AChR proteins were detected in tissue sections with 2 g/ml
polyclonal rabbit antibodies sc-14000 and sc-13998 (Santa Cruz Biotechnology,
Santa Cruz, CA). The antibodies were then visualized by use of 7.5 g/ml Alexa
488-conjugated goat anti-rabbit IgG secondary antibody (Molecular Probes,
Eugene, OR).
Stained fibers and tissue sections were imaged with a TCS NT digital camera
on a DMRXE confocal microscope (Leica Instruments, Nussloch, Germany).
NMJ areas of z-projected confocal images were calculated using ImageJ soft-
ware. The values represent averages of six experiments, where for the floxed
control, n 100; for the mutant type 1, n 81; and for the mutant type 2, n 26.
125I-labeled -bungarotoxin staining. Intact soleus muscles were dissected
from 3-month-old Gabp conditional-knockout and littermate homozygous
floxed mice and fixed in 2% (wt/vol) paraformaldehyde for 1 h at room temper-
ature. Following three rinses (5 min each) in PBS, the muscles were teased into
small fiber bundles and stained in a solution of 0.5-mg/ml acetylthiocholine
iodide (Sigma, Saint Louis, MO) dissolved in 65 mM sodium acetate (pH 6.0),
1.5 mg/ml sodium citrate, 480 g/ml cupric sulfate, and 170 g/ml potassium
ferricyanide for 30 min. Following three rinses (5 min each) in PBS, the synapse-
rich regions were dissected away from the nonsynaptic regions of muscle fibers
and then incubated in blocking solution (as described above) for 1 h at room
temperature, followed by the addition of 10 nM [3-125I]iodotyrosyl--bungaro-
toxin (Amersham Biosciences, Buckinghamshire, United Kingdom) for 4 h. The
fibers were washed three times in 0.5% (vol/vol) Triton X-100 in PBS, for 15 min
each time, prior to measurment of the radioactivity in a Packard Cobra 5005
gamma counter. Readings obtained for nonsynaptic regions were subtracted
from those of synaptic regions for each muscle and were represented as an
average of three experiments (n 18). Means were compared using an unpaired
Student’s t test; P values of less than 0.05 were taken to be statistically significant.
Neuromuscular electrophysiology. Diaphragm and soleus muscles were dis-
sected from 3-month-old Gabp conditional-knockout and littermate control
homozygous floxed mice, prepared, and stimulated as previously described (22).
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Extracellular recordings of the nerve terminal impulse (NTI), endplate currents
(EPCs), and miniature endplate currents (MEPCs) were obtained using micropi-
pettes (4-m diameter). Focal extracellular recordings were obtained by adjust-
ing the position of the electrode until both EPCs and MEPCs with rise times of
less than 1 millisecond were detected. This method of recording was chosen
because it measures the current underlying the intracellular potential changes if
the electrode is close to the release site (2, 8, 16, 22); the electrode records the
nerve terminal impulse as it passes along the nerve terminal, making it easy to
check for action potential propagation failure as the cause for failure to release
quanta (22), and the decay of the EPC gives an estimate of the closing times of
many channels (11, 20). Care was taken to ensure that the frequencies of the
EPCs and MEPCs did not change as the micropipette was lowered, since elec-
trode pressure can give rise to an increase in the spontaneous frequency (16).
Once the NMJ was located, stimulation was halted for 5 min before recording
MEPCs and EPCs to allow the terminals to replenish vesicle pools. Eight to 12
sites were selected for each muscle preparation, with at least 30 MEPCs and 100
to 200 stimulations recorded at each site. Four soleus muscles from each exper-
imental group were examined. Extracellular recording sites were included for
analysis if the frequencies of EPCs and MEPCs did not change due to electrode
pressure and if at least one EPC was recorded during the first 10 stimuli. No
correction for nonlinear summation was necessary, since all the EPCs recorded
were less then 1 mV (27). The quantal content was calculated using either the
methods of failures (if the proportion of failure to record an EPC was greater
than 30%) (9) or by dividing the mean EPC amplitudes by the mean MEPC
amplitudes (36). The rise times, decay times, and amplitudes and frequencies of
evoked (EPC) and spontaneous (MEPC) releases were calculated and tabulated
for each experimental group. The means were compared using an unpaired
Student’s t test; P values of less than 0.05 were taken to be statistically significant.
RESULTS
Generation of Gabp conditional-knockout mice. Ubiq-
uitous knockout Gabp mice die early in embryogenesis (35).
Therefore, to determine the in vivo role of Gabp in skeletal
muscle development and neuromuscular signaling, we gener-
ated mice lacking Gabp specifically in skeletal muscle. To
prevent the production of partial Gabp transcripts, we tar-
geted exon 2, the first coding exon, using the Cre-loxP system of
bacteriophage P1 (41). A single loxP site was inserted imme-
diately upstream of exon 2, and a floxed Neomycin cassette was
cloned within intron 2 (Fig. 1A, ii). This construct was trans-
fected into ES cells, and Southern blot analysis was used to
identify four heterozygous targeted Gabp ES clones (Fig.
1B). Transient transfection of Cre recombinase into targeted
FIG. 1. Conditional targeting of the Gabp locus. (A) Schematic of wild-type, targeted, floxed, and conditional-knockout Gabp alleles. A
floxed Neomycin (neo) cassette was inserted within intron 2, and a single loxP site immediately upstream of exon 2. The positions of the Southern
blot probe, PCR primers and restriction sites for BamHI (B), BalI (Bl), EcoRI (E), and HindIII (H) are shown. (B) Southern blot analysis of
genomic DNA from G418-resistant ES cells (clone numbers are shown), using a BamHI digest and an external intron 3 probe to detect 7-kb
wild-type and 5-kb targeted fragments. (C) PCR screening of puromycin-resistant targeted ES cell clones following transient Cre transfection was
performed with primers G1f and G1r, spanning Gabp introns 1 and 2 flanking the site of insertion of the neo cassette, generating 1.8-kb wild-type
(wt), 1.9-kb floxed (loxP), and 1.5-kb knockout (ko) allele products.
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clones 28 and 70 removed the Neomycin cassette to yield het-
erozygous floxed Gabp (/loxP) (Fig. 1A, iii). These clones
were identified by PCR spanning introns 1 and 2 (Fig. 1C). ES
cell clones containing the floxed Gabp allele were injected
into mouse blastocysts to yield chimeric mice. Seven lines that
transmitted the floxed Gabp allele were identified. All sub-
sequent generations of mice were genotyped using a multiplex
PCR, whereby the presence or absence of Gabp exon 2 and
the single remaining loxP site within intron 1 were confirmed
by PCR amplification with primers spanning intron 1 and ei-
ther exon 2 (wild-type and floxed alleles) or intron 2 (knockout
allele) (see Fig. S1 in the supplemental material).
Conditional loss of Gabp expression in skeletal muscle was
achieved by intercrossing mice carrying floxed Gabp and hu-
man alpha skeletal actin (hSA)-Cre alleles (Fig. 1A, iv). The
hSA-Cre mouse line expresses Cre recombinase specifically in
skeletal muscle, from embryonic day 9.5 (28). Amplification of
a 797-bp PCR product from the hSA-Cre allele confirmed the
presence of the transgene (see Fig. S1 in the supplemental
material). The resultant litters from these intercrosses gave the
expected frequency of each genotype according to Mendelian
inheritance (n  410).
Loss of Gabp expression specifically in skeletal muscle.
We characterized genomic DNA from various tissues and
showed that a 740-bp PCR product representing the Gabp
knockout allele is detected only in skeletal muscle tissues of
heterozygous and homozygous conditional-knockout mice
(Fig. 2A), consistent with specific expression of Cre recombi-
nase. The wild-type allele is represented by a 620-bp band in all
tissues, except skeletal muscle of homozygous mutants, and the
floxed Gabp allele is represented by a 660-bp band (Fig. 2A).
The presence of the floxed PCR product in skeletal muscle of
homozygous mutants indicates the presence of nonmuscle cell
types in whole-tissue lysates (Fig. 2A).
We then examined lateral and medial gastrocnemius, soleus,
vastus lateralis, and diaphragm muscles for Gabp protein
expression in floxed, heterozygous, and homozygous skeletal
muscle-specific knockout mice by Western blotting (Fig. 2B
shows a representative blot). Gabp protein levels, quantified
relative to -tubulin (see Fig. S2 in the supplemental material),
demonstrated a significant reduction (P  0.05; n  3; Student
two-tailed t test) in Gabp expression in all muscles examined
from homozygous Gabp skeletal muscle-specific knockout
mice, ranging from 25 to 55% of normal levels in the soleus
and diaphragm, respectively. Gabp expression levels in het-
erozygous mice also varied in a tissue-specific manner, from 20
to 85% of normal levels in the medial gastrocnemius and
diaphragm, respectively (data not shown). The residual Gabp
protein detected in muscle tissues of Gabp mutant mice was
likely due to heterogeneous Cre expression in multinucleated
fibers and/or the presence of nonskeletal muscle cell types in
these tissues. Immunohistochemistry of single skeletal muscle
fibers from adult Gabp mutant mice demonstrated variable
Cre expression (data not shown), and Western blot analysis of
Gabp expression in primary skeletal muscle cultures isolated
from 2- to 3-day-old pups revealed undetectable protein levels
in animals homozygous for the Gabp mutation (Fig. 2B).
We also examined protein extracts for the presence of al-
tered Gabp proteins in knockout muscle in order to confirm
that conditional targeting and deletion of Gabp exon 2 does
not result in C-terminally truncated proteins that may produce
hypomorphic or dominant-negative functions of Gabp. We
FIG. 2. Specific loss of Gabp expression in skeletal muscle. (A) PCR screening of genomic DNA extracted from organs of wild-type (/),
heterozygous (/), and homozygous knockout (/) mice. A common 5 primer within intron 1 (G2f) and 3 primers within exon 2 (G2r) and
intron 2 (G1r) generated products of 620 bp, 660 bp, and 740 bp, representing wild-type, floxed, and knockout alleles, respectively. The knockout
is represented by an asterisk in each case where no wild-type allele was detectable. (B) Western blot analysis of Gabp (58-kDa) and -tubulin
(50-kDa) protein levels in skeletal muscle tissues and primary skeletal muscle cell cultures from Gabp skeletal-muscle-specific knockout mice
(/) relative to homozygous floxed (/) littermates. Severely reduced Gabp protein levels were observed in whole muscle tissue lysates
of Gabp mutant mice and complete loss of Gabp protein expression in Gabp mutant primary skeletal muscle cells derived from mice at
postnatal days 2 and 3.
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performed Western analysis with a monoclonal antibody gen-
erated against the C terminus of Gabp (a kind gift of S.
Burden, The Skirball Institute). This antibody detected a pro-
tein product of a size similar to that of our N-terminal anti-
body, and there were no smaller (potentially truncated) pro-
teins detected in knockout muscle (data not shown). Given
that the ATP synthase coupling factor 6 gene is proximal to
Gabp and the two genes are known to share some common
regulatory elements (4), we examined whether conditional
targeting of Gabp resulted in disruption of and or aber-
rant expression of ATP synthase coupling factor 6. Real-time
RT-PCR analysis revealed no difference in expression levels
between wild-type, homozygous floxed, and homozygous
knockout muscles (data not shown).
Phenotype analysis of skeletal-muscle-specific Gabp knock-
out mice. Gabp does not appear to be essential for the growth
and development of skeletal muscle, as the body weights of
homozygous floxed and homozygous Gabp conditional-
knockout mice did not differ from 1 to 6 months of age, and
histological analysis of muscle tissue from 1- to 6-month-old
animals by hematoxylin and eosin staining and DAPI (4,6-
diamidino-2-phenylindole) staining showed no difference in
the proportions of centronucleated regenerating fibers (data
not shown). Skeletal muscle tissues were weighed at 3 months
of age, and no significant difference was found between ho-
mozygous floxed and homozygous Gabp conditional-knock-
out mice (Fig. 3A). In addition, NADH staining of fresh trans-
verse muscle sections revealed no atrophy of skeletal muscle
fibers in Gabp mutant mice (Fig. 3B). Footprint analysis
comparing the regularity of gait of Gabp skeletal-muscle-
specific knockout and homozygous floxed mice at 1, 3, and 6
months of age also revealed no differences (data not shown).
The lack of an overt phenotype in skeletal muscle of Gabp
mutant mice may be due to the high safety factor of neuro-
transmission found in mice in comparison to humans (26).
Gabp is necessary for normal NMJ formation. AChR dis-
tribution was analyzed (by staining with a Texas red conjugate
of -bungarotoxin) in lateral and medial gastrocnemius, so-
leus, and vastus lateralis muscles from homozygous floxed and
homozygous Gabp mutant mice at 1, 3, and 6 months of age,
and no difference was apparent (data not shown), indicating
that Gabp is not essential for the formation of postsynaptic
AChR clusters. We examined the gross morphology of the
NMJ by whole-mount staining for pre- and postsynaptic ele-
ments, using antibodies to synaptophysin-neurofilament and
-bungarotoxin, respectively. Individual muscle fibers were ob-
tained from soleus muscles from homozygous floxed and
Gabp mutant mice at 3 months of age. As shown by the
representative images in Fig. 4A, the morphologies of NMJs in
Gabp mutant mice were classified into two groups. First, 76%
of soleus NMJs of homozygous Gabp skeletal-muscle-specific
knockout mice showed less branching than those of homozy-
gous floxed Gabp controls but appeared relatively normal and
were classified as type 1. The remaining 24% of soleus NMJs
showed a single ring structure and were classified as type 2.
Similar proportions of the two classes of NMJs were observed
in diaphragm and sternomastoid muscles (data not shown), but
the soleus muscle was chosen for all quantification because of
the relatively large size of the NMJs.
AChR-positive areas, as determined by -bungarotoxin
staining, were quantified for both type 1 and type 2 mutant
NMJs and then expressed as percentages of the total NMJ area
(Fig. 4B). Type 1 knockout NMJs of the soleus muscle were
significantly increased in both the area occupied by AChRs and
the total area of the NMJ (P  0.0008 and P  0.0024; n  81;
Student two-tailed t test) (Fig. 4C, center column). However,
the percentage of the area occupied by AChRs was unchanged
relative to the controls. By contrast, type 2 knockout NMJs
were of equal area relative to control mice yet showed a sig-
nificant decrease in the percentage of the area occupied by
AChRs (P  0.034; n  26; Student two-tailed t test) (Fig. 4D,
right column). The increased area occupied by AChRs ob-
served in 76% of Gabp mutant NMJs (type 1 morphology)
corresponded to an observed 1.8-fold increase in the number
FIG. 3. (A) Organ weights of heart and various skeletal muscle tissues (lateral gastrocnemius, medial gastrocnemius, soleus, vastus lateralis, and
diaphragm) showed no statistical difference between samples from 1-month-old homozygous floxed (/) and Gabp skeletal-muscle-specific
knockout (/) mice. (B) NADH staining of transverse cryosections from 1-month-old homozygous floxed (/) and Gabp skeletal-muscle-
specific knockout (/) mice showing no significant difference in fiber size or tissue integrity between the two genotypes. Type I, IIb, and IIa fibers
are shown by dark, light, and intermediate staining, respectively. The images were taken at 
200 magnification.
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of AChRs found in the synaptic region of 125I-labeled -bun-
garotoxin-stained soleus muscles from 3-month-old Gabp
knockout mice in comparison to control littermates (12,559
versus 6,939 counts; P  0.013; n  9) (see Fig. S3 in the
supplemental material).
No difference in the distributions and appearance of mito-
chondria, synaptic vesicles, or postsynaptic junctional folds was
detected at the NMJs of 3-month-old Gabp skeletal-muscle-
specific knockout mice and homozygous floxed controls, as
determined by electron microscopic examination of soleus and
diaphragm muscles (data not shown).
Neuromuscular spontaneous and evoked transmitter re-
lease is reduced in Gabp mutant mice. Given the alterations
in morphology and number of postsynaptic AChRs of NMJs
from Gabp skeletal-muscle-specific knockout mice, we exam-
ined NMJ physiology in these mice. We measured evoked
EPCs, MEPCs, and the NTI at NMJs of diaphragm and soleus
muscles from Gabpmutant and homozygous floxed littermate
control mice at 3 months of age. These parameters were used
to calculate the mean quantal content, a measure of the aver-
age evoked release of acetylcholine from motor nerve termi-
nals. The NTI was recorded in every extracellular recording,
although EPCs were highly intermittent in both knockout and
control NMJs and no intermittence in the NTI was observed
throughout the recordings (Fig. 5A and E). This suggested that
the decrease in the evoked transmitter release and associated
FIG. 4. NMJ morphology in soleus muscles of Gabp conditional-knockout mice. (A) Whole-mount immunostaining of single muscle fibers
from 3-month-old control homozygous floxed (/) and homozygous Gabp skeletal-muscle-specific knockout (/) mice. NMJ shape is
revealed by AChR staining with Texas red-conjugated -bungarotoxin (Btx). Nerves and synaptic junctions were stained with a cocktail of
fluorescein isothiocyanate-conjugated antibodies against neurofilament and synaptophysin (NF-SNP). The relative positions of nerves (N), synaptic
junctions (SJ), and AChRs are indicated in the top left panel. NMJs of / mice are classified as showing less branching than those of control
mice (type 1) or single ring structures (type 2). All images are at 
1,000 magnification. (B) Schematic representation of how the AChR-positive
and total NMJ areas were defined, using the freehand tool in Image J image analysis software. The AChR-positive area was taken to be that area
stained with -bungarotoxin (btx) at the terminus of the synaptic nerve. The total NMJ area was taken to encompass the entire AChR-positive
area, leaving no internal space between the outermost branches. (C) Quantified synaptic areas occupied by AChRs, total NMJ areas (expressed
in arbitrary units  standard errors of the mean), and percentage of the area occupied by AChRs of NMJs of 3-month-old homozygous floxed
(/) and homozygous Gabp skeletal-muscle-specific knockout (/) mice. *, P  0.05 (Student’s two-tailed t test). Types 1 and 2 are the two
morphological types of NMJs observed in Gabp mutant animals at a frequency of 76% and 24%, respectively.
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increased failure rate of stimuli to evoke transmitter release in
Gabp mutant terminals were not due to failure of the action
potential to invade the nerve terminal (Fig. 5) but rather a
failure of depolarization-secretion coupling.
The amplitudes of both the MEPCs and EPCs were signif-
icantly reduced at soleus NMJs from Gabp knockout mice
compared to control mice (Fig. 5I). The mean amplitudes for
MEPCs were 171.15  25.98 V for knockout mice and
277.44  32.41 V for controls (P  0.018; n  12; Student’s
paired t test). Furthermore, the mean EPC amplitudes ap-
peared to be no greater than MEPC mean amplitudes at NMJs
from Gabp knockout NMJs (167.16  15.08 V) (Fig. 5I). By
constructing amplitude frequency histograms of MEPCs and
EPCs, we were able to estimate quantal contents. The quantal
content was significantly lower in the mutant nerve terminals
from soleus and diaphragm muscles (Fig. 5I). These results
indicated that both presynaptic and postsynaptic abnormalities
had occurred at NMJs from Gabp conditional-knockout
mice, culminating in the observed drop in the mean quantal
content.
NMJ decay constants are significantly longer in Gabp mu-
tant mice. Gabp is a key member of the ARIA/Heregulin/
FIG. 5. Extracellular recordings from NMJs of homozygous floxed control (A to D) and Gabp conditional knockout mice (E to H). Panels
A and E show examples of evoked EPCs. Panels B and F show examples of MEPCs. In panels A, B, E, and F, five consecutive traces are
superimposed. Note the invariable presence of the NTI in both control (A) and mutant (E) recordings. Frequency amplitude histograms of MEPCs
(C and G) and evoked (D and H) amplitudes are shown. The histograms shown in panels C and D were constructed from a single recording site,
as were the histograms shown in panels G and H. The distributions of MEPC amplitudes were similar in both control and Gabp conditional-
knockout mice. EPCs were skewed toward higher amplitudes in control mice, and the number of failures (black bars) was higher at NMJs from
Gabp mutant mice (H) compared to controls (D). (I) Comparison of biophysical properties of 3-month-old homozygous floxed Gabp control
(/) and Gabp conditional-knockout (/) mice. *, P  0.05; **, P  0.01; ***, P  0.001 (Student’s two-tailed t tests). (J) Representation
of MEPC decay rate constants from NMJs of Gabp conditional-knockout (hatched bars) and homozygous floxed (black bars) mice. The
histograms were constructed from a single recording site taken from either mutant or control soleus muscle. The decay rate constants for control
MEPCs varied from 10 ms to 35 ms. In contrast, the decay rate for Gabp mutant mice varied from 10 ms to 130 ms. This resulted in a significantly
longer mean in decay rates at NMJs of Gabp conditional-knockout mice than in control animals.
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Neuregulin-ErbB signal transduction pathway (17). This path-
way drives expression of the postsynaptic AChRε subunit gene,
thus triggering the change of composition of AChRs from fetal
(2) to adult (2ε) by the end of postnatal week 1,
allowing longer AChR channel opening times when ACh binds
to its receptor. We therefore examined the decay constants (a
measure of the channel opening time) at soleus and diaphragm
NMJs from 3-month-old Gabp skeletal-muscle-specific
knockout and homozygous floxed littermate control mice and
observed that the decay constants at NMJs from Gabp mu-
tant mice were significantly longer than those of control mice
(Fig. 5I and J). The mean decay constant of MEPCs for Gabp
mutant soleus NMJs was 8.27  2.25 ms, compared to 2.83 
0.33 ms for control NMJs (P  0.026; n  12; Student’s paired
t test). Similar differences were observed for diaphragm Gabp
knockout NMJs (Fig. 5I). Frequency histograms from individ-
ual recording sites typically showed a highly positive skew of
the decay constants ranging out to 100 to 150 ms in duration at
soleus and diaphragm Gabp mutant NMJs compared to 30 to
40 ms for control NMJs (Fig. 5J). The increase in the MEPC
decay constant is consistent with a failure to express sufficient
levels of AChRε, a likely consequence of Gabp gene inacti-
vation in skeletal muscles of Gabp mutant mice.
The alterations in electrophysiology of Gabp mutant NMJs
did not, however, result in any significant change in skeletal
muscle fatigability (at 1 year of age) or in strength (from 1 to
6 months of age), as determined by rotarod and wire grip tests,
respectively (data not shown).
Altered AChR expression levels in skeletal muscle of Gabp
mutant mice. In order to explain the underlying cause of
changes in NMJ structure and function in Gabp mutant mice,
we examined the expression levels of Gabp target genes. Indi-
vidual diaphragm muscles from four floxed mice and four
homozygous mutant mice at 3 months of age were studied,
using real-time RT-PCR to quantify the levels of AChR,
AChRε, and Utrophin (Fig. 6A). AChRε expression was de-
creased 10-fold (P  0.0000013; n  12; Student two-tailed t
test) in Gabpmutant diaphragms. Although the mean expres-
sion level of AChR was 50% of normal in mutant diaphragms,
the high degree of variability between floxed animals of mixed-
strain background obscured the statistical significance of these
data. Interestingly, analysis of cDNA from soleus muscles of
the same animals showed no significant difference between
genotypes (data not shown). However, a large decrease in the
mean expression level of AChR was again masked by a large
variation in floxed controls. Utrophin levels were unaltered in
skeletal muscle of Gabp knockout mice compared to their
floxed littermates (Fig. 6A), suggesting Gabp is not required
for transcriptional activation of Utrophin, at least in these tis-
sues, and immunostaining of soleus muscle fibers showed no
change in utrophin protein expression between genotypes
(data not shown).
These real-time RT-PCR data do, however, validate AChR
subunits as target genes regulated by Gabp. Furthermore, im-
munostaining of medial gastrocnemius tissue sections from
3-month-old mice with antibodies specific for AChR and
AChR expression (Santa Cruz Biotechnology, Santa Cruz,
CA) confirmed that expression of AChR protein was un-
changed in the Gabpmutant compared to homozygous floxed
controls (Fig. 6B). However, protein levels of AChR were
upregulated in the Gabp skeletal-muscle-specific knockout
animal (Fig. 6B). The fetal AChR subunit is normally re-
placed by the adult AChRε subunit within the first two post-
natal weeks in mice (29), resulting in a change in ion channel
properties. This increase in AChR protein expression corre-
lates well with the observed decrease in AChRε transcript lev-
els and explains the increased decay constants of MEPCs of
Gabp mutant mice compared to those of littermate controls.
AChR expression may also be regulated by the basic helix-
loop-helix factors myogenin and MyoD. However, we did not
observe an up-regulation of these proteins (data not shown),
indicating that altered expression of AChR subunits is due
directly to loss of Gabp expression.
DISCUSSION
We generated Gabp skeletal-muscle-specific knockout
mice that demonstrated reduced levels of the target gene
AChRε in the diaphragm, altered distribution of AChRs at the
NMJ, and abnormal neurotransmission properties, resulting
from a compensatory increase in AChR expression. This
model demonstrates an important role for Gabp in the struc-
ture and function of neuromuscular synapses.
We showed that expression of the Gabp target gene AChRε
is decreased in the diaphragms of Gabp knockout mice. A
trend toward reduced mRNA levels of AChR was observed,
and no change in Utrophin expression levels was apparent. This
indicates that other transcription factors, including other ETS
proteins, expressed in skeletal muscle cells may, to some de-
gree, compensate for loss of Gabp expression. This is sup-
ported by reduced levels of Utrophin, AChRε, and AChE in the
vastus lateralis of mice expressing a dominant-negative ETS
(comprised of the ETS DNA binding domain) protein in skel-
etal muscle (7). In addition, although our data showing de-
creased AChRε expression in the absence of Gabp function
agree with those of Briguet and Ruegg (1), an impairment in
AChR clustering was also observed following in vivo injection
of a Gabp dominant-negative construct into rat soleus muscle
fibers (1), suggesting that the milder phenotype observed in
this study may be partly explained by the ability of Gabp to
partner with another transcription factor. Interestingly, expres-
sion of a dominant-negative ETS protein results in transgenic
mice with an altered AChR morphology at the NMJ (7). These
data clearly imply a role of skeletal-muscle-expressed ETS
factors in NMJ function, and the findings are strikingly similar,
although more severe, than those described here for Gabp
skeletal muscle knockout mice.
The physiological effect of loss of Gabp expression upon
neuromuscular transmission resembles that of mice lacking the
ErbB2 and ErbB4 neuregulin receptors in skeletal muscle (15).
Like skeletal-muscle-specific Gabp knockout mice, adult
mice lacking neuregulin signaling specifically in skeletal muscle
have decreased MEPC amplitudes and low MEPC decay rates
(15). This further validates Gabp as a key effecter of the neu-
regulin-ErbB signaling pathway and emphasizes a specific
function of Gabp at the NMJ that cannot be compensated for
by other proteins.
Previous mutation studies have identified the N-box (ETS
site) as a critical element for synapse-specific expression of
both AChR (18, 23) and -ε (10). While we have shown de-
VOL. 27, 2007 ROLE OF Gabp AT THE NEUROMUSCULAR JUNCTION 3477
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
creased AChRε gene expression, this drop had no effect upon
postsynaptic localization and clustering of AChRs in muscles
of Gabp skeletal-muscle-specific knockout mice, suggesting
that Gabp is not essential for the formation of postsynaptic
AChRs. However, loss of Gabp expression does result in
altered NMJ morphology in knockout muscles. In agreement
with the phenotype of mice expressing a dominant-negative
ETS protein in skeletal muscle (7), we observed that type 2
FIG. 6. Expression of Gabp target genes in Gabp conditional-knockout mice. (A) Real-time RT-PCR analysis of transcript levels of Gabp
target genes, using cDNA from diaphragm muscles of four 3-month-old homozygous floxed (/) and homozygous Gabp skeletal muscle-specific
knockout (/) mice. The expression levels of each transcript are expressed as a ratio to -actin. The ratios were adjusted so those of floxed mice
were 1. The error bars represent standard errors of the mean. *****, P  0.000005; n  12 (two-tailed Student’s t test). Levels of Rapsyn were
measured as a negative control, as it is not a Gabp gene target. (B) Immunostaining of transverse cryosections from 3-month-old homozygous
floxed (/) and Gabp skeletal-muscle-specific knockout (/) mice with Texas red-conjugated -bungarotoxin (btx) and antibodies recognizing
AChR or AChR showing colocalization and increased expression of AChR in Gabp mutant mice. The images were taken at 
400
magnification.
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NMJs of Gabp/ soleus muscles showed a single ring struc-
ture and a significant decrease in the percentage of the area
occupied by AChRs, with the remaining type 1 NMJs showing
less branching than those of homozygous floxed Gabp con-
trols.
Type 1 NMJs of Gabp conditional-knockout mice had an
increased area compared to those of wild-type mice, but the
percentage of the area occupied by AChRs remained un-
changed. This corresponds to the observed increase in the total
number of AChRs found in the synaptic region of soleus mus-
cle tissues from Gabp conditional-knockout mice. The in-
crease in AChR protein expression in Gabp mutant mice may
be a secondary effect of loss of Gabp expression if the muscle
is responding to ineffective innervation. In addition, the
multinucleated nature of skeletal muscle cells means that vari-
able Cre splicing efficiency of Gabp in myonuclei along a
muscle fiber may result in altered neuromuscular transmission
without resulting in an overall decrease in AChR protein ex-
pression.
Together with the lower MEPC and EPC mean amplitudes
at Gabp mutant soleus NMJs, these data suggest that al-
though compensatory mechanisms may allow AChR protein
expression at the NMJ in the absence of Gabp, altered dis-
tribution of these receptor molecules within an NMJ results in
impaired neuromuscular signaling. Specifically, we observed
reduced EPC and MEPC amplitudes, leading to a 50% drop in
the mean quantal content in NMJs of Gabpmutant mice. The
longer decay times of EPCs at NMJs of the Gabp mutant
animals is explained by the observed upregulation of AChR
expression in an attempt to compensate for the loss of the
AChRε protein at the NMJs of conditional-knockout mice.
Upregulation of AChR expression has been observed in mice
lacking AChRε (43) and some humans suffering from CMS
(12), resulting in an increase in the channel opening time (and
current decay time) and a decrease in the amplitude of end-
plate potentials. However, the high safety factor of neurotrans-
mission in mice (26), together with the increased total number
of AChRs observed in synaptic regions of soleus muscles lack-
ing Gabp expression, suggests that sufficient AChRε protein
is made in the absence of Gabp expression to allow overtly
normal skeletal muscle function. The high safety factor is
clearly demonstrated by mice lacking the neuromuscular struc-
tural protein utrophin, which are healthy and show no signs of
muscle weakness despite postsynaptic abnormalities, such as
low numbers of AChRs and fewer junctional folds (6).
It would be of interest in the future to study mice of up to 2
years of age for any signs of deterioration, as the human -skel-
etal actin gene promoter used to drive Cre expression in this
study was previously shown to allow high levels of regeneration
of muscle fibers through residual gene expression in satellite
cells (31). However, no histological signs of such compensation
were visible up to 6 months of age, and preliminary rotarod
and grip analyses of Gabp mutant mice up to 1 year old
showed no loss of coordination, balance, or muscle strength.
Studies are also under way to better understand the in vivo role
of Gabp in the regulation of nuclear encoded genes of mito-
chondrial function, such as subunits of cytochrome c oxidase.
Early embryonic lethality of complete Gabp knockout mice
(35), and our preliminary results showing decreased levels of
mitochondrial transcription factor A and altered fiber type
proportions in Gabp skeletal-muscle-specific mutants (data
not shown), support the idea put forth in numerous in vitro
studies; Gabp (also known as nuclear respiratory factor 2) is
a key regulator of cellular metabolism (38).
The loss of Gabp expression in skeletal muscle results in
irregular NMJ morphology and decreased EPC amplitude,
mean quantal content, and decay time, indicating that the
Gabp complex is necessary for the development of functional
NMJs within skeletal muscle fibers. Interestingly, disruption of
Gabp function by mutation of the N box of the target gene
AChRε results in postsynaptic muscular disease. Therefore,
disruption of Gabp expression could be an underlying cause
of human diseases, such as CMS.
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